These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2763268)

  • 1. Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography.
    Medici I; Di Martino A; Cella G; Callegaro L; Prosdocimi M
    Thromb Res; 1989 May; 54(4):277-87. PubMed ID: 2763268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a high-yield expression and purification system for platelet factor 4.
    Huynh A; Arnold DM; Moore JC; Smith JW; Kelton JG; Nazy I
    Platelets; 2018 May; 29(3):249-256. PubMed ID: 29172900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycan carrier of human platelet factor 4. Isolation and characterization.
    Huang SS; Huang JS; Deuel TF
    J Biol Chem; 1982 Oct; 257(19):11546-50. PubMed ID: 7118896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet factor 4 and protamine sulphate interaction with glycosaminoglycans in the rabbit.
    Cella G; Myers CJ; Prosdocimi M; Sasahara AA
    Eur J Clin Invest; 1987 Dec; 17(6):548-54. PubMed ID: 3123254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovine platelet factor 4: purification, amino acid sequence, radioimmunoassay and comparison with platelet factor 4 of other species.
    Shigeta O; Lu WQ; Holt JC; Edmunds LH; Niewiarowski S
    Thromb Res; 1991 Nov; 64(4):509-20. PubMed ID: 1788836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
    Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
    Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and antiheparin properties of human platelet factor 4 (PF4).
    Nath N; Lowery CT; Niewiarowski S
    Blood; 1975 Apr; 45(4):537-50. PubMed ID: 803847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and binding properties of human platelet factor four.
    Handin RI; Cohen HJ
    J Biol Chem; 1976 Jul; 251(14):4273-82. PubMed ID: 819438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the chemistry of human platelet factor 4.
    Morgan FJ; Chesterman CN; McGready JR; Begg GS
    Haemostasis; 1977; 6(1):53-8. PubMed ID: 858559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.
    Amiral J; Pouplard C; Vissac AM; Walenga JM; Jeske W; Gruel Y
    Br J Haematol; 2000 May; 109(2):336-41. PubMed ID: 10848821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo studies on the binding of heparin and its fractions with platelet factor 4.
    Walz DA; Hung GL
    Semin Thromb Hemost; 1985 Jan; 11(1):40-7. PubMed ID: 2983432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human platelet factor 4: Purification and characterization by affinity chromatography. Purification of human platelet factor 4.
    Levine SP; Wohl H
    J Biol Chem; 1976 Jan; 251(2):324-8. PubMed ID: 812871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on the amino-acids associated with vascular heparan and chondroitin sulphtes.
    Manley G; Mullinger RN
    Nature; 1967 Nov; 216(5115):603-4. PubMed ID: 4230635
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of bonds formed between platelet factor 4 and negatively charged drugs using single molecule force spectroscopy.
    Block S; Greinacher A; Helm CA; Delcea M
    Soft Matter; 2014 Apr; 10(16):2775-84. PubMed ID: 24667820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of human and bovine platelet factor 4.
    Wu VY; Walz DA; McCoy LE
    Prep Biochem; 1977; 7(6):479-93. PubMed ID: 343096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of sulphate and iduronic acid residues in heparin and heparan sulphate.
    Höök M; Lindahl U; Iverius PH
    Biochem J; 1974 Jan; 137(1):33-43. PubMed ID: 4206909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C.
    Dudek AZ; Pennell CA; Decker TD; Young TA; Key NS; Slungaard A
    J Biol Chem; 1997 Dec; 272(50):31785-92. PubMed ID: 9395524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of heparin-binding growth factors from porcine uterus.
    Brigstock DR; Heap RB; Barker PJ; Brown KD
    Biochem J; 1990 Feb; 266(1):273-82. PubMed ID: 2310377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serglycin-binding proteins in activated macrophages and platelets.
    Kolset SO; Mann DM; Uhlin-Hansen L; Winberg JO; Ruoslahti E
    J Leukoc Biol; 1996 Apr; 59(4):545-54. PubMed ID: 8613703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.